Rac1 in the driver's seat for melanoma

Pigment Cell and Melanoma Research

Volumn 25, Issue 6, 2012, Pages 762-764

  Machesky, Laura M ^a   Sansom, Owen J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; B RAF KINASE; CYTIDINE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MIXED LINEAGE KINASE 3; P21 ACTIVATED KINASE 1; RAC1 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THYMIDINE; VAV PROTEIN;

BINDING SITE; CANCER GROWTH; CANCER PATIENT; CELL CYCLE PROGRESSION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONFORMATIONAL TRANSITION; DOWNSTREAM PROCESSING; DRUG TARGETING; ENZYME ACTIVATION; EXOME; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GENOME; HUMAN; IN VITRO STUDY; INTRACELLULAR SIGNALING; MELANOMA; MELANOMA CELL; MELANOMA METASTASIS; MOLECULARLY TARGETED THERAPY; NOTE; ONCOGENE; ONCOGENE N RAS; STATISTICAL SIGNIFICANCE; SUN EXPOSURE; URINARY TRACT CANCER;

ANIMALS; CELL MOVEMENT; ENZYME INHIBITORS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; MELANOMA; MODELS, BIOLOGICAL; RAC1 GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84867912469     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/pcmr.12004     Document Type: Note

References (27)

1. Bartolome, R.A., Molina-Ortiz, I., Samaniego, R., Sanchez-Mateos, P., Bustelo, X.R., and Teixido, J. (2006). Activation of Vav/Rho GTPase signaling by CXCL12 controls membrane-type matrix metalloproteinase-dependent melanoma cell invasion. Cancer Res. 66, 248-258.
2. Berger, M.F., Hodis, E., Heffernan, T.P. et al. (2012). Melanoma genome sequencing reveals frequent PREX2 mutations. Nature, 485, 502-506.
3. Blokx, W.A., Van Dijk, M.C., and Ruiter, D.J. (2010). Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects. Histopathology 56, 121-132.
4. Brown, J.L., Stowers, L., Baer, M., Trejo, J., Coughlin, S., and Chant, J. (1996). Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr. Biol. 6, 598-605.
5. Davies, H., Bignell, G.R., Cox, C. et al. (2002). Mutations of the BRAF gene in human cancer. Nature 417, 949-954.
6. Frost, J.A., Swantek, J.L., Stippec, S., Yin, M.J., Gaynor, R., and Cobb, M.H. (2000). Stimulation of NFkappa B activity by multiple signaling pathways requires PAK1. J. Biol. Chem. 275, 19693-19699.
7. Gadea, G., Sanz-Moreno, V., Self, A., Godi, A., and Marshall, C.J. (2008). DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells. Curr. Biol. 18, 1456-1465.
8. Gysin, S., Salt, M., Young, A., and Mccormick, F. (2011). Therapeutic strategies for targeting ras proteins. Genes Cancer 2, 359-372.
9. Heasman, S.J., and Ridley, A.J. (2008). Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat. Rev. Mol. Cell Biol. 9, 690-701.
10. Hodis, E., Watson, I.R., Kryukov, G.V. et al. (2012). A landscape of driver mutations in melanoma. Cell 150, 251-263.
11. Insall, R.H., and Machesky, L.M. (2009). Actin dynamics at the leading edge: from simple machinery to complex networks. Dev. Cell 17, 310-322.
12. Jefferies, C.A., and O'neill, L.A. (2000). Rac1 regulates interleukin 1-induced nuclear factor kappaB activation in an inhibitory protein kappaBalpha-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression. J. Biol. Chem. 275, 3114-3120.
13. Kamai, T., Shirataki, H., Nakanishi, K., Furuya, N., Kambara, T., Abe, H., Oyama, T., and Yoshida, K. (2010). Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer. BMC Cancer 10, 164.
14. Krauthammer, M., Kong, Y., Ha, B.H. et al. (2012). Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. doi: 10.1038/ng.2359 [Epub ahead of print].
15. Lazer, G., and Katzav, S. (2011). Guanine nucleotide exchange factors for RhoGTPases: good therapeutic targets for cancer therapy? Cell. Signal. 23, 969-979.
16. Li, A., Ma, Y., Yu, X. et al. (2011). Rac1 drives melanoblast organization during mouse development by orchestrating pseudopod- driven motility and cell-cycle progression. Dev. Cell 21, 722-734.
17. Li, A., Ma, Y., Jin, M., Mason, S., Mort, R.L., Blyth, K., Larue, L., Sansom, O.J., and Machesky, L.M. (2012). Activated mutant NRas(Q61K) drives aberrant melanocyte signaling, survival, and invasiveness via a Rac1-dependent mechanism. J. Invest. Dermatol. doi: 10.1038/jid.2012.186. [Epub ahead of print].
18. Lindsay, C.R., Lawn, S., Campbell, A.D. et al. (2011). P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat. Commun. 2, 555.
19. Murga, C., Zohar, M., Teramoto, H., and Gutkind, J.S. (2002). Rac1 and RhoG promote cell survival by the activation of PI3K and Akt, independently of their ability to stimulate JNK and NF-kappaB. Oncogene 21, 207-216.
20. Ong, C.C., Jubb, A.M., Zhou, W., Haverty, P.M., Harris, A.L., Belvin, M., Friedman, L.S., Koeppen, H., and Hoeflich, K.P. (2011). p21-activated kinase 1: PAK'ed with potential. Oncotarget 2, 491-496.
21. Poulikakos, P.I., and Rosen, N. (2011). Mutant BRAF melanomas - dependence and resistance. Cancer Cell 19, 11-15.
22. Roring, M., and Brummer, T. (2012). Aberrant B-Raf signaling in human cancer - 10years from bench to bedside. Crit. Rev. Oncog. 17, 97-121.
23. Saci, A., Cantley, L.C., and Carpenter, C.L. (2011). Rac1 regulates the activity of mTORC1 and mTORC2 and controls cellular size. Mol. Cell 42, 50-61.
24. Sanz-Moreno, V., Gadea, G., Ahn, J., Paterson, H., Marra, P., Pinner, S., Sahai, E., and Marshall, C.J. (2008). Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510-523.
25. Sugihara, K., Nakatsuji, N., Nakamura, K. et al. (1998). Rac1 is required for the formation of three germ layers during gastrulation. Oncogene 17, 3427-3433.
26. Wherlock, M., and Mellor, H. (2002). The Rho GTPase family: a Racs to Wrchs story. J. Cell Sci. 115, 239-240.
27. Yang, J., and Weinberg, R.A. (2008). Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 14, 818-829.